360关系网 - 360微门户 - 360度的人脉 - 噻唑烷二酮类药物 (Thiazolidinedione drugs)

噻唑烷二酮类药物 (Thiazolidinedione drugs)

加入本微门户

微门户首页

	JCEM:脂联素在骨密度调控中发挥作用 0条评论已读[34] 发布： 2013/10/20 15:25:53 在校正年龄、性别、体重指数、平均动脉压、吸烟状况、糖化血红蛋白A1c、噻唑烷二酮类药物使用和低密度脂蛋白胆固醇前后,脂联素与胸椎和腰椎vBMD(参数估计(PEs)分别...
更多
	FDA专家小组六月召开的会议可能会使罗格列酮迅速撤市 0条评论已读[36] 发布： 2013/10/20 15:25:48 罗格列酮是一种噻唑烷二酮类糖尿病药物;2010年9月份,欧洲药品管理局认为罗格列酮的心血管风险超过其收益,决定暂停该药物的市场销售。然而,FDA虽然认为罗格列酮...
更多
	AJG:降糖药与胰腺癌发病风险的关系尚不明确 0条评论已读[35] 发布： 2013/10/20 15:25:38 在胰腺癌危险因素的研究中,有些显示糖尿病患者服用二甲双胍和噻唑烷二酮类药物有防癌的功效,而另一些研究则显示降糖药物并无此类功效。为了更好的了解降糖药物是否...
更多
	Takeda Presents Additional Results from EXAMINE Cardiovascular Safety Outcomes ... - PR Newswire UK (press release) 0条评论已读[27] 发布： 2013/10/19 15:24:02 PR Newswire UK (press release) Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration's (FDA) 2008 Guidance, titled "Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to ... and more »
更多
	Takeda Presents Additional Results from EXAMINE Cardiovascular Safety Outcomes ... - PR Newswire UK (press release) 0条评论已读[26] 发布： 2013/10/18 15:23:39 PR Newswire UK (press release) Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration's (FDA) 2008 Guidance, titled "Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to ... and more »
更多
	Takeda Presents Additional Results from EXAMINE Cardiovascular Safety Outcomes ... - PR Newswire UK (press release) 0条评论已读[26] 发布： 2013/10/17 15:22:58 PR Newswire UK (press release) Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration's (FDA) 2008 Guidance, titled "Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to ... and more »
更多
	Takeda Presents Additional Results from EXAMINE Cardiovascular Safety Outcomes ... - PR Newswire UK (press release) 0条评论已读[26] 发布： 2013/10/16 15:25:55 PR Newswire UK (press release) Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration's (FDA) 2008 Guidance, titled "Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to ... and more »
更多
	Takeda Presents Additional Results from EXAMINE Cardiovascular Safety Outcomes ... - PR Newswire UK (press release) 0条评论已读[25] 发布： 2013/10/15 15:22:59 PR Newswire UK (press release) Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration's (FDA) 2008 Guidance, titled "Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to ... and more »
更多
	Takeda Presents Additional Results from EXAMINE Cardiovascular Safety Outcomes ... - PR Newswire UK (press release) 0条评论已读[26] 发布： 2013/10/14 15:24:18 PR Newswire UK (press release) Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration's (FDA) 2008 Guidance, titled "Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to ... and more »
更多
	Takeda Presents Additional Results from EXAMINE Cardiovascular Safety Outcomes ... - PR Newswire UK (press release) 0条评论已读[26] 发布： 2013/10/13 15:22:33 PR Newswire UK (press release) Takeda conducted the global EXAMINE trial in accordance with the United States (U.S.) Food and Drug Administration's (FDA) 2008 Guidance, titled "Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to ... and more »
更多

« 上一页 | 查看结果231-240共483 | 下一页 »

新闻分类

Industry News

政策法规

市场分析

企业动态

行业评论

人物访谈

新闻标签：

没有标签

最新报告

求职招聘